Company
UbiquiTx
Programmable protein modulation.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- partners
Claim, correct or request removal
Record updated 17 September 2026
About
We have a rich toolkit for editing the genome and transcriptome, but an equivalent framework for the proteome has remained elusive. UbiquiTx has built an AI-native platform for programmable modulation of the proteome — turning any protein target into one we can precisely modulate, not just knock out.
Loading relationship preview